BD | Diabetes on the Net

It looks like you're using an unsecure version of Internet Explorer. Using an outdated browser makes your computer unsafe. For the best and safest website experience, please update your or please use or

Company Profile

BD Diabetes Care have been specialising in the design and manufacture of insulin needles and syringes for over 90 years. BD’s culture of innovation and continuous improvement has enhanced the patient experience to enable better diabetes therapy and outcomes. BD and Me™ and BD Injection technique training programmes for HCPs and patients, have been designed to provide information on correct injection technique to better manage diabetes for those injecting¹.

>1.Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013 Oct;39(5):445-53. doi: 10.1016/j.diabet.2013.05.006. Epub 2013 Jul 22.

This resource page and the materials included have been organised and funded by BD

Company Profile

Resources

Managing insulin injections in your practice

Micro-Fine Ultra

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form